Suprachoroidal implant surgery in intractable glaucoma.

Area of Science:

• Ophthalmology
• Glaucoma Surgery
• Ocular Implants

Background:

• Intractable glaucoma presents a significant challenge in managing intraocular pressure (IOP).
• Current treatment options may have limitations or side effects.
• Novel surgical approaches are needed to improve IOP control.

Purpose of the Study:

• To evaluate the early clinical outcomes of suprachoroidal silicone implant surgery.
• To assess the efficacy of this novel technique in managing intractable glaucoma.

Main Methods:

• A modified, valveless silicone implant was surgically placed into the suprachoroidal space.
• The procedure was performed on 15 eyes diagnosed with intractable glaucoma.
• Patient outcomes were monitored over a mean follow-up period of 17.1 months.

Main Results:

• Mean intraocular pressure (IOP) decreased significantly from 33.1 mmHg preoperatively to 16.5 mmHg postoperatively (p = 0.001).
• Functional success (IOP ≤21 mmHg) was achieved in 93.3% of cases.
• The average number of antiglaucomatous medications reduced from 3.8 to 2.2 (p = 0.011).
• Shallow choroidal detachment, indicating successful drainage, was observed in all patients.

Conclusions:

• Suprachoroidal silicone implant surgery is an effective method for reducing IOP in intractable glaucoma.
• This technique facilitates aqueous humor drainage into the suprachoroidal space.
• The procedure offers a promising alternative for managing complex glaucoma cases.